InvestorsHub Logo
Followers 27
Posts 1719
Boards Moderated 0
Alias Born 01/18/2020

Re: Vader69 post# 35042

Thursday, 02/04/2021 7:58:08 AM

Thursday, February 04, 2021 7:58:08 AM

Post# of 44690
This is from the article.

In a January 26 preprint paper, for example, researchers demonstrated that the SARS-CoV-2 variant that emerged in South Africa was "markedly more resistant" to antibodies in convalescent plasma, and "completely or markedly abolished" the activities of Lilly's bamlanivimab and Regeneron's casirivimab on their own. But Regeneron's imdevimab appeared to retain its function.